Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

177 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PROTOCOL: Barriers and facilitators to stakeholder engagement in health guideline development: A qualitative evidence synthesis.
Magwood O, Riddle A, Petkovic J, Lytvyn L, Khabsa J, Atwere P, Akl EA, Campbell P, Welch V, Smith M, Mustafa RA, Limburg H, Dans LF, Skoetz N, Grant S, Concannon T, Tugwell P. Magwood O, et al. Among authors: skoetz n. Campbell Syst Rev. 2022 Apr 25;18(2):e1237. doi: 10.1002/cl2.1237. eCollection 2022 Jun. Campbell Syst Rev. 2022. PMID: 36911345 Free PMC article.
Hodgkin's lymphoma in adults: diagnosis, treatment and follow-up.
Rancea M, Engert A, von Tresckow B, Halbsguth T, Behringer K, Skoetz N. Rancea M, et al. Among authors: skoetz n. Dtsch Arztebl Int. 2013 Mar;110(11):177-83, 183e1-3. doi: 10.3238/arztebl.2013.0177. Epub 2013 Mar 15. Dtsch Arztebl Int. 2013. PMID: 23555321 Free PMC article.
Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial.
Behringer K, Goergen H, Hitz F, Zijlstra JM, Greil R, Markova J, Sasse S, Fuchs M, Topp MS, Soekler M, Mathas S, Meissner J, Wilhelm M, Koch P, Lindemann HW, Schalk E, Semrau R, Kriz J, Vieler T, Bentz M, Lange E, Mahlberg R, Hassler A, Vogelhuber M, Hahn D, Mezger J, Krause SW, Skoetz N, Böll B, von Tresckow B, Diehl V, Hallek M, Borchmann P, Stein H, Eich H, Engert A; German Hodgkin Study Group; Swiss Group for Clinical Cancer Research; Arbeitsgemeinschaft Medikamentöse Tumortherapie. Behringer K, et al. Among authors: skoetz n. Lancet. 2015 Apr 11;385(9976):1418-27. doi: 10.1016/S0140-6736(14)61469-0. Epub 2014 Dec 22. Lancet. 2015. PMID: 25539730 Clinical Trial.
[German-language translation of the PANELVIEW instrument to evaluate the guideline development process from the perspective of the guideline group].
Goossen K, Becker M, Mathes T, Follmann M, Holtkamp U, Hostettler S, Meerpohl JJ, Nothacker M, Schaefer C, Schmidt S, Schünemann HJ, Sommer I, Tholen R, Skoetz N, Pieper D. Goossen K, et al. Among authors: skoetz n. Z Evid Fortbild Qual Gesundhwes. 2022 Feb;168:106-112. doi: 10.1016/j.zefq.2021.11.004. Epub 2022 Jan 22. Z Evid Fortbild Qual Gesundhwes. 2022. PMID: 35078748 German.
Third biannual report of the Cochrane Haematological Malignancies Group.
Kober T, Skoetz N, Trelle S, Bohlius J, Engert A; Cochrane Haematological Malignancies Group. Kober T, et al. Among authors: skoetz n. J Natl Cancer Inst. 2005 Aug 17;97(16):E2. doi: 10.1093/jnci/dji258. J Natl Cancer Inst. 2005. PMID: 16106014 Review. No abstract available.
177 results